Sensei Biotherapeutics Appoints Patrick Gallagher, MBA, MPH, as Chief Business Officer
yahoo.com
finance
2022-06-01 11:30:00

Sensei Biotherapeutics

BOSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), an immunotherapy company focused on the discovery and development of next-generation therapeutics for cancer, today announced the appointment of Patrick Gallagher, MBA, MPH, as chief business officer.



'Patrick is an accomplished biotech executive who brings significant strategic and transactional expertise to Sensei. He has worked across the biotechnology, Big Pharma, venture and banking sectors and has a track record of tailoring partnerships and transactions to build value,' said John Celebi, president and chief executive officer of Sensei Biotherapeutics.
